Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „weeks“
Suchtreffer
Begriffe & Kennungen
Baraclude · 4.8 · Treatment beyond 48 weeks: continued treatment with entecavir for a median duration of 96 weeks did not reveal
Eintrag öffnenBavencio · 4.8 · 15 The median time to onset of immune-mediated colitis was 5.1 months (range: 2.3 weeks to 14 months). The med
Eintrag öffnenBavencio · 4.8 · The median time to onset of immune-mediated adrenal insufficiency was 5.5 months (range: 3.6 weeks to 8.7 mont
Eintrag öffnenBavencio · 4.8 · The median time to onset of immune-mediated hepatitis was 2.3 months (range: 2.1 weeks to 14.5 months). The me
Eintrag öffnenBavencio · 4.8 · The median time to onset of immune-mediated nephritis was 1.2 months (range: 2.9 weeks to 1.8 months). The med
Eintrag öffnenBavencio · 4.8 · The median time to onset of immune-mediated nephritis was 2.4 months (range: 7.1 weeks to 21.9 months). The me
Eintrag öffnenBavencio · 4.8 · The median time to onset of thyroid disorders was 2.8 months (range: 2 weeks to 12.8 months). The median durat
Eintrag öffnenBavencio · 4.8 · The median time to onset of thyroid disorders was 2.8 months (range: 3.6 weeks to 19.3 months). The median dur
Eintrag öffnenBeovu · 4.8 · DME After dosing with Beovu for 96 weeks, treatment-emergent anti-brolucizumab antibodies were detected in 16-
Eintrag öffnenBeovu · 4.8 · Wet AMD After dosing with Beovu for 88 weeks, treatment-emergent anti-brolucizumab antibodies were detected in
Eintrag öffnenBesremi · 4.5 · Administration of 180 micrograms of pegylated interferon alfa-2a once weekly for 4 weeks in healthy male subje
Eintrag öffnenBeyfortus · 4.8 · Table 1 presents the adverse reactions reported in 2 966 term and preterm infants (GA ≥29 weeks) who received
Eintrag öffnenBimzelx · 4.8 · Approximately 44% of patients with AS treated with bimekizumab up to 52 weeks at the recommended dosing regime
Eintrag öffnenBimzelx · 4.8 · Approximately 45% of plaque psoriasis patients treated with bimekizumab up to 56 weeks at the recommended dosi
Eintrag öffnenBimzelx · 4.8 · Approximately 57% of patients with nr-axSpA treated with bimekizumab up to 52 weeks at the recommended dosing
Eintrag öffnenBimzelx · 4.8 · Approximately 59% of HS patients treated with bimekizumab up to 48 weeks at the recommended dosing regimen (32
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenCabometyx · 4.8 · In a dataset of cabozantinib 40 mg once daily in combination with nivolumab 240 mg every two weeks in RCC (n =
Eintrag öffnenCapecitabine Teva · 4.8 · For the capecitabine dose of 1250 mg/m2 twice daily on days 1 to 14 every 3 weeks, a frequency of 53% to 60% o
Eintrag öffnen